ResearcherEli Lilly (United States)No recent work listed

Steven J. Nicol

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5111681727. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2011: 1 paper

Papers 1

Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: results of a phase II, randomized, noncomparative… Last author DOI 10.1007/s10637-009-9307-8 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Donald Richards · 1 shared paper, 2011 · strength 0.02
- Paper Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: results o… DOI 10.1007/s10637-009-9307-8 ↗
Lalan S. Wilfong · 1 shared paper, 2011 · strength 0.02
- Paper Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: results o… DOI 10.1007/s10637-009-9307-8 ↗
Carlos Roberto Becerra · 1 shared paper, 2011 · strength 0.02
- Paper Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: results o… DOI 10.1007/s10637-009-9307-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.